In-Hospital Mortality and Its Predictors among Hospitalized Diabetes Patients: A Prospective Observational Study

Table 3

Prevalence of comorbidities among patients with DM admitted to JMC from October 01, 2020, to June 30, 2021.

Variables		Frequency (n = 120)	(%)
Presence of comorbidities	Yes	87	72.5
	No	33	27.5
Type of comorbidities (n = 87)
Cardiovascular diseases	Hypertension	51	58.62
	Congestive heart failure (CHF)	19	21.84
	Ischemic cardiomyopathy (ICMP)	10	11.49
	Acute coronary syndrome (ACS)	10	11.49
	Stroke	8	9.19
	Hypertensive heart disease (HHD)	8	9.19
	Deep vein thrombosis (DVT)	6	6.89
	Systolic dysfunction	5	5.75
	Others	4	4.59
Infections	Pneumonia	35	40.23
	Urinary tract infection (UTI)	10	11.49
	Bacterial meningitis	7	8.04
	Pyelonephritis	6	6.89
	Tuberculosis (TB)	6	6.89
	COVID-19	5	5.75
	Skin and soft tissue infections (SSTI)	5	5.75
	Others^‡	2	2.29
Kidney diseases^†		20	22.98
Gastrointestinal diseases^╫		10	11.49
Anemia		7	8.04
Other comorbidities^$		2	2.29

Atrial fibrillation, all types of shocks, and ischemic heart disease (IHD). ^‡Human immunodeficiency virus/acquired immunodeficiency syndrome, sepsis, and malaria. ^†Acute kidney injury, nephrolithiasis, and chronic kidney disease. ^╫Chronic liver disease, peptic ulcer disease; ^$cancers (cervical and acute myeloid leukemia, hyperkalemia, and hyponatremia.